Streptococcus gallolyticus subsp. pasteurianus, previously known as Streptococcus bovis biotype II.2, is an uncommon pathogen in neonates. Nevertheless, it can cause severe neonatal sepsis and meningitis often clinically indistinguishable from those caused by group B streptococci and has been associated with considerable morbidity. We report the first known cases of S. gallolyticus subsp. pasteurianus infection in twin infants.
T win B, a 3-week-old diamniotic, dichorionic twin male at Texas Children's Hospital Pavilion for Women, had a 1-day history of pale color, lethargy, poor feeding, and increased irritability. He was born at 32 weeks of gestation, weighing 2,120 g, to a 26-year-old primigravida mother via Cesarean section because of severe preeclampsia. The mother had an unknown group B streptococcal (GBS) status and did not receive antibiotic prophylaxis during delivery. Immediately following his birth, the patient developed respiratory distress requiring intubation and surfactant. He was transported to the neonatal intensive care unit (NICU) for further management and continued to improve in the NICU until day of life (DOL) 24, when he was found to have pale color, loose stool, respiratory distress, and hypoxemia. Within the next few hours, he also experienced mild hypothermia. A full sepsis workup was initiated, and empirical parenteral vancomycin (15 mg/kg of body weight every 12 h), gentamicin (4 mg/kg every 24 h), and ceftazidime (40 mg/kg every 8 h) were initiated. Approximately 6 h after the onset of his symptoms, the child developed acute respiratory failure, requiring intubation, and refractory hypotension, requiring dopamine infusion. Two hours later, he developed new-onset seizures that progressed to epilepticus status. The chest radiograph revealed coarse markings within the lungs, with superimposed mild volume loss in the right upper lobe.
Initial laboratory studies are presented in Table 1 . The cerebrospinal fluid (CSF) white blood cell (WBC) differential was not available. Degenerated inflammatory cells, including monocytes and neutrophils, were reported. The CSF Gram stain revealed Gram-positive cocci in clusters, with many WBCs. (The initial Gram stain from the original specimen was reported as "in clusters," likely due to the appearance of very small clusters [1 to 3 cocci] along with pairs.) However, when the Gram staining was performed from colonies on solid media, Gram-positive cocci in pairs were found, consistent with what occurs with Streptococcus species.
The peripheral, aerobic blood culture was positive for Grampositive cocci in pairs and chains at 8 h in the VersaTREK microbial detection system (TREK Diagnostic Systems, Cleveland, OH). The initial CSF culture for twin B revealed abundant gammahemolytic streptococci, not enterococci, identified as Streptococcus gallolyticus subsp. pasteurianus with 99% probability and excellent identification (confidence level) by the GP identification card on the Vitek 2 platform (software version 4.01; bioMérieux, USA). The urine culture was negative. Parenteral ampicillin (75 mg/kg every 6 h) was initiated, and all other antibiotics were discontinued.
Over the next few days, twin B's clinical course continued to deteriorate. He experienced continuous seizures accompanied by myoclonus, with abnormal electroencephalographic studies. He was given multiple blood products for worsening anemia and thrombocytopenia and electrolyte supplementation for moderate hyponatremia and hyperkalemia. A head ultrasound obtained on the first day of illness showed normal anatomy; however, a magnetic resonance image of the brain with and without contrast taken 4 days after onset demonstrated moderate lateral, third-and fourth-ventricular hemorrhage with secondary mild dilatation of the lateral and third ventricles and without evidence of acute infarction, parenchymal abscess, or empyema (Fig. 1) . Repeat head ultrasound 2 days later showed grade 3 intraventricular hemorrhage, which then remained stable, and the infant gradually improved without further complications for the rest of his admission. Repeat blood cultures after 24 h and 48 h of antibiotic treatment were negative. A repeat CSF culture after 6 days of antibiotic treatment showed Gram-positive cocci by Gram staining, but the culture was negative. Twin B was treated with ampicillin for a total of 14 days from CSF clearance.
Twin A, the 3-week-old sister of twin B, was born weighing 1,474 g and exhibited similar symptoms of respiratory distress immediately after delivery. Resuscitation included positive-pressure ventilation and continuous positive airway pressure, but no intubation or surfactant was required. On DOL 24, she experienced intermittent tachypnea and underwent a full sepsis workup due to the severe infection in twin B. The results of subsequent laboratory studies are presented in Table 1 . Initial CSF studies showed colorless, hazy cerebrospinal fluid, and the CSF Gram stain revealed no organisms and was culture negative. The blood culture was positive for Gram-positive cocci in pairs after 11 h. Twin A remained hemodynamically stable despite positive blood cultures and was treated with intravenous ampicillin (75 mg/kg every 6 h). She completed a 10-day course and was discharged upon completion of therapy.
Further analysis of the organisms growing in the blood culture from twin A and blood and CSF cultures from twin B were identified as Streptococcus gallolyticus using pyrosequencing of three hypervariable regions (V1, V3, and V6) of the 16S rRNA gene (1). Briefly, extracted bacterial DNA (MagNA Pure liquid chromatography [LC] total nucleic acid isolation kit; Roche Applied Science, IN) was used as the template in PCRs with universal primers targeting the conserved regions directly flanking the variable regions. The resulting sequence was searched against the Ribosomal Database Project (RDP) maintained by Michigan State University and the SmartGene Integrated Database Networking System (IDNS) (SmartGene, Inc., Raleigh, NC) (2, 3). The 16S rRNA gene was amplified by PCR using primers 8F and 1541R (1), and the products were sequenced at SeqWright Inc. (Houston, TX). The sequences were compared to the corresponding region of published 16S sequences of related species and subspecies, deposited in GenBank, using MEGA 5.1 (4). The neighbor-joining tree (Fig. 2) shows an alignment of the twin isolates with S. gallolyticus subsp. pasteurianus, and a 100% sequence match was observed by nucleotide BLAST analysis alignment with ATCC 43144 (5-8; http: //blast.ncbi.nlm.nih.gov/).
Analysis of the twins' isolates by pulsed-field gel electrophoresis using previously described methods and digestion with SmaI revealed that the twins' isolates were identical, suggesting that the twins were infected by the same strain (9, 10; data not shown). Antimicrobial susceptibility testing by Etest using Clinical and Laboratory Standards Institute (CLSI) guidelines (29) demon- Hemorrhage in the cisterna magna inferior to the cerebellar vermis. strated susceptibility to ampicillin (MIC, 0.125 g/ml), penicillin (MIC, 0.125 g/ml), cefotaxime (MIC, 0.25 g/ml), and vancomycin (MIC, 0.5 to 1 g/ml) for all the isolates.
Streptococcus gallolyticus subsp. pasteurianus is a highly unusual pathogen in neonates. Only a few case reports exist. This is the first report of infection by this organism in neonatal twins. The pathogen has been associated with considerable morbidity and, in some cases, mortality over the last 4 decades. The strain was previously recognized as Streptococcus bovis biotype II/2, but its taxonomy has been revised. Originating as one of the six DNA groups of the S. bovis/S. equinus complex (11), it was later subdivided into biotype II based on its inability to ferment mannitol (11) and then into biotype II/2 based on phenotypic testing and sequencing of its sodA gene (12) . In the last 10 years, biochemical tests have further differentiated biotypes I and II into distinct subspecies, and new species nomenclature has replaced the old biotype classification (11) . The three species formerly known as S. bovis biotype II.2, S. waius, and S. macedonicus were grouped into one DNA cluster but show limited DNA-DNA relatedness and sufficient divergence in their 16S rRNA genes sequences to be separable (5, 12, 13) . Reclassified as S. gallolyticus subsp. pasteurianus, S. gallolyticus subsp. gallolyticus, and S. gallolyticus subsp. macedonicus, the three subspecies differ biochemically (12, 14) . S. gallolyticus subsp. pasteurianus can be differentiated from other subspecies based on betagalactosidase (BGAL) and beta-glucuronidase (BGAR) tests, by which S. gallolyticus subsp. pasteurianus is positive while S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. macedonicus are negative. While the Vitek platform results are commonly reported only at the species level by clinical laboratories, a study of Grampositive bacteria using the Vitek 2 GP identification card showed 100% accuracy in the identification of three Streptococcus gallolyticus subsp. pasteurianus isolates; none of the other 214 isolates of the Streptococcaceae family, including 4 subsp. gallolyticus isolates, were identified as this species (15) . The Vitek biochemical panel includes the BGAL and BGAR biochemical tests. The present case reports show a 100% 16S rRNA alignment of the two neonatal isolates to the previously confirmed strain Streptococcus gallolyticus subsp. pasteurianus ATCC 43144 and positive BGAL and BGAR biochemical tests, confirming the identity of the isolated pathogens and further supporting the previous notion that distinct differences between subspecies can be reliably detected by Vitek and confirmed by 16S sequencing (5, 13, 15 ).
While S. bovis (biotype I), part of a normal colonic microbiota, has long been associated with colonic neoplasia and bacterial endocarditis in adults, the clinical significance of S. bovis biotype II, particularly within the neonatal population, has been less well established (16) . Over the last 2 decades, however, a small, but growing, pool of literature has described invasive infections in neonates and infants. Most of these cases have been sporadic and document bacterial sepsis with or without accompanying meningitis in neonates less than 24 h to 2 months of age with severe disease rarely described in those older than 1 week of age (13, 17) . Almost all of the patients presented with gastrointestinal symptoms and responded well to a 2-week course of a penicillin derivative, with minimal complications (13) . In recent years, similar infections in adults have been reported, and some have even documented relative penicillin and gentamicin resistance, making careful evaluation and awareness of this pathogen imperative (16, (18) (19) (20) .
As with patterns of early-and late-onset GBS disease, invasive S. gallolyticus subsp. pasteurianus infection presumably occurs either via an ascending route (early-onset) or via vaginal delivery or postnatally from maternal or caretaker contact, infected breast milk, or nosocomial sources (21). Fikar and Levy reported a neonate with S. bovis meningitis whose mother had the same organism growing from rectal and vaginal cultures (22) . In 2006, the first outbreak of S. gallolyticus subsp. pasteurianus bloodstream infections was reported, and it involved five preterm infants in a university hospital neonatal intensive care unit in France, implicating hand carriage and poor sterile procedures (23) . The exact pathophysiology of S. bovis group meningitis is unclear, though recent studies have suggested the gastrointestinal tract as a possible source. Noble demonstrated that S. bovis was isolated more frequently from the stool samples of neonates (5/21, 23.8%) than from adults (2/39, 5%) (24), while Gerber et al. reported a high prevalence of abdominal symptoms (5/7, 71%) in infants with systemic S. bovis infection without isolation of the pathogen from the stool (25) . More recently, Takahashi et al. isolated identical isolates of S. gallolyticus subsp. pasteurianus from blood, CSF, and stool, suggesting translocation of previously commensal bacteria, with initiation of bacteremia and subsequent systemic dissemination and infiltration into CSF as a possible mechanism (26) . In our case, no further investigation into the source of the organism was pursued.
Twin gestation is a known risk factor for the development of invasive GBS disease, but its role in other neonatal infections remains unclear. Within the former process, the relative risk of invasive GBS infection in the twin of an affected neonate has been reported to be as high as 25-fold (27) . Prematurity and precipitous labor further increase susceptibility to infection (28) . While studies of neonatal S. gallolyticus subsp. pasteurianus infections are limited, we hypothesize that the pathogeneses of its disease are similar. Furthermore, the extreme variability of the clinical presentations of these twins raises important questions regarding management of neonatal infection in twins. The neonates in our case not only differed in their presentations, with prominent respiratory rather than gastrointestinal symptoms, but also demonstrated two extremes of possible sequelae in the disease course. While one twin was mildly symptomatic, the other twin faced an unusually severe course for a late-onset infection, including overwhelming sepsis with serious neurologic damage, a complication that has rarely been reported. One previous report regarding S. gallolyticus subsp. pasteurianus meningitis included two infants with seizure-like activity but none with neurologic sequelae (13) .
In summary, these cases broaden the clinical diversity of neonatal infections in twins and also highlight the importance of a thorough evaluation of both twins in the setting of suspected sepsis, regardless of the presence of symptoms (28) .
